$0.9590
0.54128.33%
Last update: Oct 20, 4:00 PM
AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc.
ATXIOTCID
AVENUE THERAPEUTICS INC by Avenue Therapeutics fell 59.3% from $0.75 to $0.31, behind the S&P 500's +10.0%. Its worst day was Feb 26 (−36.2%), and its low came Feb 11 at $0.15.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.21 was reported on $0.00 revenue.
0.0% · S&P 500 0.0%
AVENUE THERAPEUTICS INC by Avenue Therapeutics closed at its highest level of the year, 19.1% above where the year started.
Story events cover the past 12 months · Times ET
+13.7%
AVENUE THERAPEUTICS INC by Avenue Therapeutics closed at its lowest level of the year, 80.0% below where the year started.
−21.7% · S&P 500 0.0%
AVENUE THERAPEUTICS INC by Avenue Therapeutics shares rose 86.7%, while the S&P 500 fell 1.0%.
+86.7%, the year's best day · S&P 500 −1.0%
EPS of $-0.22 was reported on $0.00 revenue.
+20.7% · S&P 500 +0.8%
EPS of $-0.21 was reported on $0.00 revenue.
−3.7% · S&P 500 +0.8%
AVENUE THERAPEUTICS INC by Avenue Therapeutics shares rose 57.8%, while the S&P 500 rose 0.7%.
+57.8% · S&P 500 +0.7%
EPS of $-0.21 was reported on $0.00 revenue.
−15.1% · S&P 500 +0.6%
AVENUE THERAPEUTICS INC by Avenue Therapeutics shares rose 59.2%, while the S&P 500 rose 0.3%.
+59.2% · S&P 500 +0.3%
EPS of $-0.20 was reported on $0.00 revenue.
−28.8% · S&P 500 +2.4%
Where it ended: a close of $0.31 on Nov 9, 2026.
Nothing in the past 12 months.
All ATXI analyst actionsNothing in the past 12 months.
All ATXI dividend history
